Pediatric COVID-19 Follow-up Clinic

Norton Children’s Infectious Diseases, affiliated with the UofL School of Medicine, offers a COVID-19 Follow-up Clinic for children and teens experiencing effects after a confirmed or suspected diagnosis of COVID-19, the disease caused by the coronavirus.

If your child is experiencing severe COVID-19 symptoms or multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, go directly to the Norton Children’s Hospital emergency department.

Children and teens may feel unwell for a prolonged amount of time after confirmed or suspected illness with COVID-19. The COVID-19 Follow-up Clinic aims to help families receive additional laboratory tests or any subspecialist referrals that their child may need.

Who Can Be Seen in the COVID-19 Follow-up Clinic?

Before a child can be referred to the clinic, they will:

  • Need to have a proven or strongly suspected COVID-19 diagnosis
  • Need to be without a fever (without using fever-reducing medicines)
  • Be 10 days past the first time they experienced symptoms and/or received a positive COVID-19 test
  • Need to still feel unwell with symptoms
  • Need a referral from the child’s pediatrician or other health care provider

This clinic is separate from the Norton Children’s Pediatric MIS-C Multidisciplinary Clinic. The MIS-C clinic is intended for follow-up of children discharged from the hospital.

Children can be seen by a pediatric infectious diseases specialist as soon as the day after receiving a physician referral to the COVID-19 Follow-up Clinic. Appointments are available in person and via telehealth through a MyNortonChart account.

My Child Didn’t Have to Go to the Hospital After Being Diagnosed With COVID-19 and Recovered. Are We in the Clear?

In most children, COVID-19 is mild and children fully recover without the need for ongoing treatment. Even after mild COVID-19 illness, middle and high school athletes should be cleared by their primary care provider before returning to play. If your child has symptoms that last more than two weeks, they may benefit from evaluation at the clinic.

Infectious Disease – 5437

Norton Children’s Infectious Diseases

Call for Information

(502) 588-2348

Pediatric COVID-19 Follow-up Clinic

A referral is required for clinic services. Call your child’s pediatrician or (502) 629-KIDS for a referral to the clinic.


COVID-19 Vaccines

Norton Children’s has opened COVID-19 vaccination appointments for kids ages 6 months and older.
Schedule Online

COVID-19 Tests

Schedule Online

Call (502) 861-4611, option 1

Symptoms of hand, foot and mouth disease

Hand, foot and mouth disease symptoms include the small red sores that often appear in the mouth and rashes that appear on the palms of the hands and soles of the feet and that give […]

Read Full Story

Respiratory syncytial virus (RSV) in infants can lead to respiratory conditions later

There is increasing evidence that severe respiratory syncytial virus (RSV) infections in young children can have long-term effects such as wheezing and asthma, according to Ronald L. Morton, M.D.,  pediatric pulmonologist with Norton Children’s Pulmonology, […]

Read Full Story

Summertime RSV outbreak may signal prolonged traditional RSV season

The respiratory syncytial virus (RSV) outbreak of 2021 brought unprecedented summertime levels of the infection to states like Kentucky, raising some concerns about the traditional cold-weather season for RSV. At Norton Children’s, health care providers […]

Read Full Story

Local cases of RSV, croup on the rise

While most virus news continues to be about the one that causes COVID-19, there are several other viruses affecting local children. Last week, the Centers for Disease Control and Prevention (CDC) issued a health advisory […]

Read Full Story

Norton Children’s Research Institute, affiliated with the UofL School of Medicine, to participate in COVID-19 investigational vaccine clinical trial for children ages 6 months to 4 years

The Norton Children’s Research Institute, affiliated with the UofL School of Medicine, will participate in a phase 2/3 clinical trial of the Pfizer-BioNTech COVID-19 investigational vaccine for healthy children ages 6 months to 4 years. […]

Read Full Story

Search our entire site.